Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
Abstract Background This study aimed to evaluate the visual and morphological outcomes of intravitreal anti-VEGF therapy and the recurrence for idiopathic choroidal neovascularization (ICNV). Methods This retrospective study included 35 patients (35 eyes) with ICNV from July 2012 to October 2017. Al...
Main Authors: | Qianru Wu, Xiaoyong Chen, Kang Feng, Yuling Liu, Chun Zhang, Lin Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-020-01390-4 |
Similar Items
-
Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
by: Bhatia D, et al.
Published: (2021-06-01) -
Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
by: T Lekha, et al.
Published: (2015-01-01) -
CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH BEST’S DISEASE
by: Cristina Nieto Gómez, et al.
Published: (2016-04-01) -
Intravitreal topotecan inhibits laser-induced choroidal neovascularization in a rat model
by: Mohammad Ali Gholipour, et al.
Published: (2015-01-01) -
Idiopathic choroidal neovascular membrane in a young female
by: Saad Abdullah Waheeb, et al.
Published: (2009-01-01)